Advertisement RainDance launches ASDSeq, XSeq research screening panels - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

RainDance launches ASDSeq, XSeq research screening panels

RainDance Technologies has introduced ASDSeq and XSeq Research Screening Panels, which are developed in partnership with Emory University and Greenwood Genetic Center.

The screening panels allow researchers to simultaneously examine key genes that are associated with X-chromosome disorders and syndromic forms of Autism Spectrum Disorder (ASD).

The RainDance ASDSeq and XSeq panels utilises the company’s microdroplet-based targeted sequencing technology.

Emory Genetics Laboratory senior director Madhuri Hegde said the RainDance panels allow them to focus on the specific genetic mutations that contribute to autism and other X-linked disorders.